SK Bioscience Co Ltd (302440) — Financial Flexibility Index
SK Bioscience Co Ltd (302440) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of ₩91.59 Billion (operating CF ₩20.65 Billion minus capex ₩70.94 Billion) represents 0% of total liabilities (₩847.96 Billion). Check how aggressively does SK Bioscience Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SK Bioscience Co Ltd Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for SK Bioscience Co Ltd across 7 annual periods. For the full cash flow conversion analysis, see SK Bioscience Co Ltd cash flow conversion.
Annual Financial Flexibility Index for SK Bioscience Co Ltd (2018–2024)
Year-by-year free cash flow to debt coverage for SK Bioscience Co Ltd. Explore 302440 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.05x | ₩44.20 Billion | ₩-128.02 Billion | ₩821.14 Billion | ▼ -90.0% |
| 2023 | 0.54x | ₩79.64 Billion | ₩29.35 Billion | ₩148.58 Billion | ▲ +542.6% |
| 2022 | -0.12x | ₩-48.47 Billion | ₩-124.96 Billion | ₩400.23 Billion | ▼ -110.6% |
| 2021 | 1.14x | ₩579.50 Billion | ₩536.59 Billion | ₩508.81 Billion | ▲ +161.2% |
| 2020 | 0.44x | ₩130.15 Billion | ₩120.22 Billion | ₩298.44 Billion | ▲ +63.1% |
| 2019 | 0.27x | ₩45.79 Billion | ₩21.82 Billion | ₩171.25 Billion | ▲ +142.0% |
| 2018 | 0.11x | ₩21.21 Billion | ₩14.90 Billion | ₩191.98 Billion | — |